Fan Yu
@Ally Bridge Group (ny) Llc
Latest period2024 - Q3ReportedManaged Assets$186.813MTotal holdings29
Assets growth rate11.3%Assets growth rate (2-Q avg)2.31%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Ally Bridge Group (ny) Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 29 positions.
Assets under management
The assets under management (AUM) of Ally Bridge Group (ny) Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 186.813M in assets, with a quarterly growth rate of 11.3% and a 2-quarter average growth rate of 2.31%. The portfolio is managed by Fan Yu, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
SRPTSarepta Therapeutics Inc
| 4.82% | $8.992M 72,000 shares@ $124.89 avg price | Decreased -2.04% |
GERNGeron Corp
| 3.24% | $6.043M 1.331M shares@ $4.55 avg price | Decreased -51.36% |
KURAKura Oncology Inc
| 3.08% | $5.746M 294,081 shares@ $19.55 avg price | Decreased -4.13% |
IRONDisc Medicine Inc
| 2.64% | $4.914M 100,000 shares@ $49.14 avg price | Decreased -39.93% |
CATXPerspective Therapeutics Inc
| 2.45% | $4.562M 341,739 shares@ $13.36 avg price | Decreased -13.75% |
MNMDMind Medicine Mindmed Inc
| 2.41% | $4.487M 788,508 shares@ $5.7 avg price | Decreased -18.32% |
ALMSAlumis Inc
| 2.4% | $4.469M 418,416 shares@ $10.69 avg price | Decreased -32.37% |
TRVITrevi Therapeutics Inc
| 2.37% | $4.418M 1.323M shares@ $3.34 avg price | Decreased -10.31% |
PRAXPraxis Precision Medicines I
| 2.26% | $4.211M 73,185 shares@ $57.55 avg price | Decreased -52.28% |
CNTXContext Therapeutics Inc
| 1.85% | $3.445M 1.758M shares@ $1.96 avg price | Decreased -6.82% |